We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > chronic obstructive pulmonary disease

News List

Invion spin-off selects leading CRO for nadolol development biospectrumasia
September 29, 2018
Chronic Airway Therapeutics (CAT) selects R&G Pharma to progress Chinese development of nadolol
The Lancet Respiratory Medicine publishes first Phase III trial for PT010 triple combination therapy in moderate to very severe chronic obstructive pulmonary disease worldpharmanews
September 18, 2018
AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide/ glycopyrronium/formoterol fumarate) versus dual combination therapies Bevespi Aeros